Mackenzie Financial Corp bought a new position in shares of Genesco Inc. (NYSE:GCO - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 13,937 shares of the company's stock, valued at approximately $596,000. Mackenzie Financial Corp owned about 0.12% of Genesco as of its most recent filing with the Securities and Exchange Commission (SEC).
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Rhumbline Advisers boosted its holdings in shares of Genesco by 1.5% during the fourth quarter. Rhumbline Advisers now owns 19,146 shares of the company's stock worth $818,000 after purchasing an additional 281 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its stake in Genesco by 4.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 14,392 shares of the company's stock worth $616,000 after buying an additional 650 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. purchased a new stake in Genesco in the 4th quarter valued at about $35,000. Wells Fargo & Company MN grew its holdings in Genesco by 28.1% in the 4th quarter. Wells Fargo & Company MN now owns 5,846 shares of the company's stock valued at $250,000 after buying an additional 1,281 shares during the period. Finally, Barclays PLC increased its stake in shares of Genesco by 7.2% during the 4th quarter. Barclays PLC now owns 22,228 shares of the company's stock valued at $950,000 after acquiring an additional 1,498 shares during the last quarter. 94.51% of the stock is owned by hedge funds and other institutional investors.
Genesco Trading Up 2.6%
NYSE GCO traded up $0.59 during mid-day trading on Thursday, hitting $22.88. The company's stock had a trading volume of 290,646 shares, compared to its average volume of 216,702. The firm has a market capitalization of $246.59 million, a P/E ratio of -9.46 and a beta of 2.14. The company has a debt-to-equity ratio of 0.19, a current ratio of 1.56 and a quick ratio of 0.32. Genesco Inc. has a 52-week low of $16.19 and a 52-week high of $44.80. The stock's fifty day simple moving average is $20.59 and its two-hundred day simple moving average is $30.94.
Genesco (NYSE:GCO - Get Free Report) last issued its earnings results on Wednesday, June 4th. The company reported ($2.05) EPS for the quarter, beating analysts' consensus estimates of ($2.06) by $0.01. Genesco had a negative net margin of 1.13% and a positive return on equity of 0.56%. The business had revenue of $473.97 million for the quarter, compared to the consensus estimate of $463.90 million. During the same quarter last year, the firm posted ($2.10) EPS. The business's revenue for the quarter was up 3.6% compared to the same quarter last year. Research analysts expect that Genesco Inc. will post 0.94 EPS for the current year.
Insider Transactions at Genesco
In other news, Director Gregory A. Sandfort bought 10,974 shares of the firm's stock in a transaction dated Thursday, March 20th. The stock was acquired at an average cost of $22.92 per share, for a total transaction of $251,524.08. Following the completion of the purchase, the director now owns 26,754 shares of the company's stock, valued at $613,201.68. This trade represents a 69.54% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, major shareholder Fund 1 Investments, Llc sold 12,000 shares of Genesco stock in a transaction on Friday, March 28th. The stock was sold at an average price of $20.73, for a total transaction of $248,760.00. Following the sale, the insider now directly owns 1,097,850 shares in the company, valued at $22,758,430.50. This trade represents a 1.08% decrease in their position. The disclosure for this sale can be found here. Company insiders own 23.11% of the company's stock.
Analyst Ratings Changes
Several equities analysts recently commented on the stock. Wall Street Zen lowered shares of Genesco from a "buy" rating to a "hold" rating in a research report on Friday, May 30th. Truist Financial upped their price objective on Genesco from $23.00 to $25.00 and gave the stock a "hold" rating in a report on Thursday. Finally, Jefferies Financial Group reaffirmed a "hold" rating and issued a $24.00 target price (down from $27.00) on shares of Genesco in a research report on Wednesday, May 21st.
Get Our Latest Stock Analysis on Genesco
Genesco Profile
(
Free Report)
Genesco Inc operates as a retailer and wholesaler of footwear, apparel, and accessories in the United States, Puerto Rico, Canada, the United Kingdom, and the Republic of Ireland. The company operates through four segments: Journeys Group, Schuh Group, Johnston & Murphy Group, and Genesco Brands.
Read More

Before you consider Genesco, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genesco wasn't on the list.
While Genesco currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.